Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99,248 | -70,638 | -40,110 | 158,519 | 188,412 |
| Depreciation Amortization | 21,785 | 14,376 | 7,120 | 33,102 | 17,742 |
| Accounts receivable | -26,222 | 9,260 | 17,175 | 129,171 | 40,291 |
| Accounts payable and accrued liabilities | -1,852 | -2,827 | -5,778 | -2,094 | -1,151 |
| Other Working Capital | 11,816 | 4,658 | -22,913 | 29,825 | 832 |
| Other Operating Activity | 69,455 | 21,011 | 443 | -71,163 | 322 |
| Operating Cash Flow | $-24,266 | $-24,160 | $-44,063 | $277,360 | $246,448 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -111,975 | -112,750 | -102,583 | -253,351 | -252,192 |
| PPE Investments | -62,516 | -42,185 | -14,984 | -70,660 | -58,330 |
| Purchase Of Investment | -37,317 | -36,757 | -34,735 | -43,048 | -37,140 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -2,000 | -2,000 |
| Other Investing Activity | 15,023 | 7,693 | 2,693 | 14,434 | 12,100 |
| Investing Cash Flow | $-196,785 | $-183,999 | $-149,609 | $-352,625 | $-335,562 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,560 | N/A | N/A | 2,755 | 2,406 |
| Common Stock Issued | 1,080 | 824 | 490 | N/A | N/A |
| Other Financing Activity | -1,049 | -863 | -948 | -4,383 | -4,383 |
| Financing Cash Flow | $6,591 | $-39 | $-458 | $-1,628 | $-1,977 |
| Exchange Rate Effect | -479 | 584 | -213 | -9,599 | -9,963 |
| Beginning Cash Position | 414,651 | 414,651 | 414,650 | 501,142 | 501,142 |
| End Cash Position | 199,712 | 207,037 | 220,307 | 414,650 | 400,088 |
| Net Cash Flow | $-214,939 | $-207,614 | $-194,343 | $-86,492 | $-101,054 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,266 | -24,160 | -44,063 | 277,360 | 246,448 |
| Capital Expenditure | -62,516 | -42,185 | -14,984 | -70,660 | -58,330 |
| Free Cash Flow | -86,782 | -66,345 | -59,047 | 206,700 | 188,118 |